2021 Insights on COVID-19 Vaccines – Opportunity Assessment and Forecast to 2026

By Laverne J. Tiffany 3 years ago

DUBLIN, July 14, 2021–(Small business WIRE)–The “Coronavirus Disorder 2019 (COVID-19) Vaccines – Opportunity Evaluation and Forecast to 2026” report has been extra to ResearchAndMarkets.com’s supplying.

This report offers a COVID-19 condition overview, epidemiology overview, current promoted vaccines, unmet desires, pipeline evaluation, and market place outlook.

The publisher forecasts 3 various prospective scenarios for the future use of COVID-19 vaccines:

  • The initially scenario assumes that yearly vaccination with a COVID-19 vaccine will be necessary.

  • The 2nd circumstance assumes yearly vaccination for the higher-danger inhabitants of men and women 65 several years of age and more mature, although every person under 65 yrs of age will want a vaccine only just about every two years.

  • In the third situation, the superior-danger population of people 65 several years of age and more mature will receive a COVID-19 vaccine each two a long time, even though every person under 65 several years will require a vaccine only every five decades.

Companies Described

  • Pfizer

  • BioNTech

  • Moderna

  • AstraZeneca

  • Johnson & Johnson

  • Novavax

  • CureVac

  • Sanofi

  • GlaxoSmithKline

  • Arcturus

  • Medicago

  • Valneva

  • Inovio

This report involves:

  • Executive Summary

  • Illness Overview: Record of the outbreak, Etiology and Pathophysiology

  • Epidemiology

  • Current Vaccination Choices: Features detailed products profiles with SWOT evaluation

  • Unmet Require and Alternatives: Detailing the important unmet desires with significant KOL insights

  • Pipeline Evaluation: Consists of pipeline overview and in-depth merchandise profiles with SWOT assessment

  • R&D Tactics: Tendencies in Scientific Trial Design for COVID-19 Vaccines and Developments in Offer-Earning

  • Marketplace Outlook

Explanations to Buy

  • Establish and layout your in-licensing and out-licensing procedures through a evaluation of pipeline items and technologies, and by pinpointing the companies with the most robust pipeline.

  • Create enterprise strategies by being familiar with the developments shaping and driving the 7MM COVID-19 vaccine.

  • Generate revenues by comprehending the key trends, progressive solutions and systems, market place segments, and firms possible to impact the world-wide COVID-19 vaccine current market in the long term.

  • Formulate productive revenue and marketing and advertising tactics by knowing the competitive landscape and by analyzing the overall performance of different competition.

  • Detect rising gamers with possibly sturdy products portfolios and build productive counter-approaches to acquire a competitive edge.

  • Organize your product sales and marketing initiatives by determining the current market groups and segments that current utmost chances for consolidations, investments, and strategic partnerships.

Critical Matters Protected:

1. Govt Summary

2. Disorder Overview

3. Epidemiology

4. Current Vaccination Alternatives

5. Unmet Requires and Opportunities

6. Pipeline Assessment

7. R&D Approaches

8. Current market Outlook

9. Appendix

10. Contact the Publisher

For much more information and facts about this report take a look at https://www.researchandmarkets.com/r/an2xjw.

Look at supply version on businesswire.com: https://www.businesswire.com/news/property/20210714005747/en/

Contacts

ResearchAndMarkets.com
Laura Wooden, Senior Push Supervisor
[email protected]

For E.S.T. Office Hrs Get in touch with 1-917-300-0470
For U.S./CAN Toll Cost-free Phone 1-800-526-8630
For GMT Place of work Hrs Phone +353-1-416-8900

Tags: , , , , ,